the company has also recently acquired obesity drug developer Metsera, along with another experimental GLP-1 drug
This new drug, already available for diabetes, has potential to bring us closer to truly effective obesity treatment without surgery
it's a game-changer for your health, fitness, and overall well-being
Research areas where laboratories buy AOD-9604 for in vitro work include lipolysis and lipid-metabolism assays in adipocyte cell models, comparative studies of GH fragments versus intact growth hormone on metabolic readouts, and IGF-1-independent metabolic-pathway research
Building on the momentum of the GLP-1 space and beyond, companies including Eli Lilly, Pfizer, Novo Nordisk, and Amgen have all introduced DTP platforms
Always consult a registered healthcare provider before making medical decisions.